Joyce Tozer

Consultant anaesthetist for the procedure on the 12th June 2015,gave evidence that since Mrs. Tozer'$ death, he has become concerned that the dose of 10Oml omnipaque record in the notes as being administered by the radiologist minutes before Tozer'$ sudden deterioration was well in excess of the dose recommended by the manufacturer of omnipaque (1ml/kg) especially as it was administered through & central line rather than peripheral venous access At this time Mrs Tozer' $ weight was 52kg) stated that he was concerned that the administration of a hypertonic solution at this dose into a central line may have affected Mrs. Tozer's heart rhythm although there was no way he could give an opinion as to whether it was the likely cause of her deterioration and death as the presentation of toxicity cannot be distinguished from an anaphylactoid reaction Igave evidence that having made enquiries about the dose with Lead Interventional Radiologist at the Trust, he has been told that a 10Oml dose is often used. am concerned that doses of omnipaque well in excess the and has during May line Mrs. being of the manufacturer' s guidelines are frequently administered, sometimes through central lines, and this practice could be exposing interventional radiology patients to risks from toxicity: